E Wróblewska1. 1. II Kliniki Okulistyki AM w Lublinie.
Abstract
PURPOSE: The aim of this study was to evaluate Schirmer test I and BUT in patients after long-term topical antiglaucoma medication. MATERIAL AND METHODS: 59 glaucoma patients on stable regimen of one or two antiglaucoma drugs (for a minimum 1 year) and 30 healthy people were checked for changes of the precorneal tear film. Tear secretion was measured by Schirmer test I and stabilization of precorneal film by break-up time. RESULTS: We found no influence of antiglaucoma drugs on tear secretion. Statistically significant decrease in break-up time was found in glaucoma patients. CONCLUSIONS: Long-term topical antiglaucoma medication may alter precorneal film stabilization.
PURPOSE: The aim of this study was to evaluate Schirmer test I and BUT in patients after long-term topical antiglaucoma medication. MATERIAL AND METHODS: 59 glaucomapatients on stable regimen of one or two antiglaucoma drugs (for a minimum 1 year) and 30 healthy people were checked for changes of the precorneal tear film. Tear secretion was measured by Schirmer test I and stabilization of precorneal film by break-up time. RESULTS: We found no influence of antiglaucoma drugs on tear secretion. Statistically significant decrease in break-up time was found in glaucomapatients. CONCLUSIONS: Long-term topical antiglaucoma medication may alter precorneal film stabilization.